Stay updated on Remibrutinib Long-term Extension in Urticaria Clinical Trial

Sign up to get notified when there's something new on the Remibrutinib Long-term Extension in Urticaria Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Remibrutinib Long-term Extension in Urticaria Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    15 days ago
    Change Detected
    Summary
    Taoyuan District, Taiwan, 33305 was removed. Taoyuan, Taiwan, 33305 was added in the Locations list, updating the Taiwan site address to reflect current administrative naming.
    Difference
    0.0%
    Check dated 2026-05-01T21:58:06.000Z thumbnail image
  3. Check
    22 days ago
    Change Detected
    Summary
    Updated the ClinicalTrials.gov page’s displayed revision/version label from v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-24T17:07:10.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. This appears to be a backend version update and does not modify study content or user-facing features.
    Difference
    0.0%
    Check dated 2026-04-17T14:09:36.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    Revision: v3.5.0 has been added and v3.4.3 has been removed.
    Difference
    0.0%
    Check dated 2026-03-19T23:48:42.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Added new study locations across multiple countries (examples include Uskudar, Melikgazi, Karsiyaka, Karabaglar, Efeler, Buca, Atakum, Adapazari, Hajdu Bihar Megye, Hesse, Bavaria, Cundinamarca, and more) and removed numerous sites; total locations updated from 207 to 208.
    Difference
    2%
    Check dated 2026-03-12T20:42:18.000Z thumbnail image
  7. Check
    93 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.1 to v3.4.2, indicating a minor UI/version change. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-12T02:22:05.000Z thumbnail image

Stay in the know with updates to Remibrutinib Long-term Extension in Urticaria Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Remibrutinib Long-term Extension in Urticaria Clinical Trial page.